Consolidated Statements of Changes in Shareholders’ (Deficit) Equity - USD ($)	Common Stock	Additional Paid-in Capital	(Accumulated Deficit) Retained Earnings	Total
Balance at Dec. 31, 2021	$ 431	$ 24,569	$ (7,048)	$ 17,952
Balance (in Shares) at Dec. 31, 2021	4,312,500
Sale of 8,537,500 Private Placement Warrants		8,537,500		8,537,500
Issuance of Representative Shares	$ 45	3,463,629		3,463,674
Issuance of Representative Shares (in Shares)	450,000
Fair value of Public Warrants at issuance		3,379,730		3,379,730
Allocated value of transaction costs to Common Stock		(340,594)		(340,594)
Accretion of common stock subject to redemption amount		(15,054,352)		(15,054,352)
Net income			1,231,665	1,231,665
Balance at Dec. 31, 2022	$ 476	10,482	1,224,617	1,235,575
Balance (in Shares) at Dec. 31, 2022	4,762,500
Accretion of common stock subject to redemption amount		(10,482)	(4,410,109)	(4,420,591)
Excise taxes related to redemptions			(1,551,962)	(1,551,962)
Net income			3,167,019	3,167,019
Balance at Dec. 31, 2023	$ 476		$ (1,570,435)	$ (1,569,959)
Balance (in Shares) at Dec. 31, 2023	4,762,500